NONSEGMENTAL VITILIGO: DECREASE OF THE CD45RA+ T‐CELL SUBSET AND EVIDENCE EOR PERIPHERAL T‐CELL ACTIVATION

International Journal of Dermatology

Volumn 31, Issue 5, 1992, Pages 321-326

  ABDEL‐NASER, M BADAWY ^a,b   LUDWIG, WOLF‐DIETER ^a,b   GOLLNICK, HARALD ^a,b   ORFANOS, CONSTANTIN E ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Ain Shams University Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VITILIGO;

ADOLESCENT; ADULT; B-LYMPHOCYTES; FEMALE; HLA-DR ANTIGENS; HUMAN; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; VITILIGO;

EID: 0026588010     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1992.tb03946.x     Document Type: Article

References (39)

1. Vitiligo. What is it? Is it important
2. Vitiligo and multiple glandular insufficiencies
3. Vitiligo, thyroid disease and autoimmunity
4. Alopecia universalis, onycho‐dystrophy and total vitiligo
5. Hypoparathyroidism, candidiasis, alopecia and vitiligo
6. Lupus érythémateux et vitiligo
7. Vitiligo and pernicious anemia
8. Vitiligo in diabetes mellitus
9. Hyperpigmentation, vitiligo and Addison's disease
10. Erhöhte Expression des 0KM5‐Antigens auf Blutmonozyten bei Vitiligo
11. Vitiligo. Peripheral T cell subset imbalance as defined by monoclonal antibodies
12. Aberrations in T lymphocytes and natural killer cells in vitiligo. A flow cytometry study
13. T cell profiles in vitiligo
14. Natural cell‐mediated cytotoxicity in vitiligo
15. Circadian rhythm of natural killer cell activity in vitiligo
16. T cell subpopulations in vitiligo: a chronobiologic study
17. Peripheral T cell subset imbalance in patients with vitiligo and their apparently healthy first degree relatives
18. Immunozytologie
19. Procedural guidelines for performing immunophenotyping by flow cytometry
20. Towards a better definition of human leucocyte surface molecules
21. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system
22. Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B and K cell traffic in the peripheral blood
23. T‐cell memory: the connection between function, phenotype and migration pathways
24. Relative and absolute numbers of human lymphocyte subpopulations. A comparison with special reference to precision and reference values
25. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus
26. Abnormalities in CD4+ T lymphocyte subsets in inflammatory rheumatic disease
27. A defect of immunoregulatory T cell subsets in systemic lupus erythetnatosus patients demonstrated with anti‐2H4 antibody
28. Role of the 2H4 molecule in the activation of suppressor inducer function
29. Relation ship between systemic lupus erythematosus T cell sub sets, anti T cell antibodies and T cell functions
30. Myasthenia gravis, rheumatoid arthritis, vitiligo and autoimmune hemolytic anemia
31. Essential requirement for major histocompatibility complex recognition in T cell tolerance induction
32. The structure, function and expression of interleukin 2 receptors on normal and malignant lymphocytes
33. Induction by IL‐1 and interferon gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM‐1)
34. HLA‐DR antigen expression on peripheral T cell subsets in pityriasis rosea and herpes zoster
35. Increased HLA‐ DR+ T lymphocyte population in peripheral blood of alopecia areata
36. Sequential expression of T cell activation (Tac) antigen and la deter minants on circulating human T cells after immunization with tetanus toxoid
37. Histopathology of vitiliginous skin
38. Evidence for primary involvement of keratinocytes in vitiligo (Abstr.)
39. The preferential accumulation of helper‐inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion